Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for hematologic cancers or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Plasma Cell Neoplasms

Drugs mentioned

• Cyclosporine Eye Drops (cyclosporine)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-12-08